ArticleCureus2025
Laparoscopic Transcystic SpyGlass Discover-Assisted Common Bile Duct Exploration and Clearance: An Efficient and Cost-Effective Alternative for Common Bile Duct Stone Management.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Minimally invasive surgical strategies for gallbladder stones with concomitant common bile duct stones: a systematic review and network meta-analysis.BMC surgery · 2026Pooled it
- Transcystic biliary tract exploration during single-stage treatment for cholecystitis/symptomatic cholelithiasis plus choledocholithiasis using the SpyGlass system: a favorable therapeutic proposal.Journal of surgical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim This study aimed to assess the safety and efficacy of laparoscopic transcystic SpyGlass Discover (Boston Scientific Corporation, Marlborough, MA, USA) common bile duct (CBD) exploration combined with laparoscopic cholecystectomy (LC) as a single-stage procedure for patients requiring cholecystectomy and confirmed, suspected, or complex CBD stones. The study also evaluated the cost-effectiveness of this single-stage procedure compared to the two-stage endoscopic retrograde cholangiopancreatography (ERCP) followed by LC. The study adhered to the local clinical governance unit protocol and the Strengthening the Reporting of Cohort Studies in Surgery (STROCSS) guidelines. Materials and methods This is a retrospective cohort study conducted from January 2023 to July 2024. The safety, efficacy, and cost-effectiveness of SpyGlass Discover CBD exploration performed by a single consultant were evaluated. Of the sample population, 38 patients who underwent CBD stone management were included. Twenty-one patients (Group 1) had SpyGlass Discover CBD exploration planned, while 17 patients (Group 2) underwent the conventional preoperative ERCP followed by LC. All adult patients undergoing planned management were included. Data for comparison included age, gender, length of hospital stay, operative time, and success rates. Results Twenty-one patients underwent a single-stage operation using SpyGlass Discover. In nine cases, CBD exploration was performed, but no intervention was needed. In five cases, intervention was required, consisting of two laser lithotripsies and two mechanical lithotripsies with a basket. Seven cases had OTC, which showed a clear duct. The total operative time for Group 1 was 146 minutes on average. For those who did not require intervention, the mean operative time was 117 minutes, while the mean operative time for cases requiring intervention was 175 minutes. In Group 2, the mean operative time for ERCP + LC was 131 minutes. The length of hospital stay for Group 1 averaged 1.25 days, while Group 2 had an average of 1.52 days. Conclusions It was concluded that one-stage LC combined with SpyGlass Discover-assisted transcystic CBD clearance is an effective, safe, and cost-effective procedure when performed by skilled hands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.